Effect of Physical Rehabilitation in Patients With Parkinson's Disease
NCT ID: NCT06021834
Last Updated: 2023-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2023-09-01
2023-10-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There will be two measurement sessions, one pre-intervention and one post-intervention (measuring cardiorespiratory parameters, evaluating dynamic and static postural balance, and assessing cognitive function).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Home Rehabilitation of Balance Based on Functional Exercises in People With Parkinson's Disease
NCT04963894
Effect of Adding Computerized Cognitive Training on Balance, Locomotion and Cognition in Parkinson's Disease
NCT06104072
Rehabilitation of Postural Abnormalities in Parkinson's Disease
NCT03741959
Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease
NCT02816619
The Effectiveness of Motor-motor and Motor-cognitive Dual-task Training Interventions on Balance in People With Parkinson's Disease: a Feasibility Study
NCT05710588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There will be two measurement sessions, one pre-intervention and one post-intervention (measuring cardiorespiratory parameters, evaluating dynamic and static postural balance, and assessing cognitive function).
The recruited subjects will be randomly assigned to two groups: a control group and an experimental group. The subjects will be invited to attend the program three times per week.
The control group will engage in an endurance training program, while the experimental group will participate in a combined endurance training and cognitive training program
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
The control group will be invited to attend the program three times per week and will engage in an endurance training program
rehabilitation
The subjects will be invited to attend the program three times per week.
experimental group
the experimental group will be invited to attend the program three times per week and will participate in a combined endurance training and cognitive training program.
rehabilitation
The subjects will be invited to attend the program three times per week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rehabilitation
The subjects will be invited to attend the program three times per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to moderate stage according to the Hoehn and Yahr scale.
* No hearing or visual impairments that could hinder the integration and implementation of the rehabilitation protocol.
* Has the ability to communicate and walk.
* Patient has been stable on treatment for 3 months.
Exclusion Criteria
* A Montreal Cognitive Assessment score (MoCA ) of less than 24.
* A current psychiatric disorder that could make it difficult or dangerous to adhere to the research protocol.
* Musculoskeletal impairments or excessive pain in any joint that could limit participation in an exercise program.
* Treatment with sedative medications
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculty of Medicine, Sousse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ghazoua Nafti
Principal Investigator Ghazoua NAFTI
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Faculté de Médecine de Sousse
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.